RemovedRisk Factors
We have identified and remediated material weaknesses in the past and may in the future discover areas of our internal financial and accounting controls and procedures that need improvement. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, regardless of how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems,
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements, and we or our independent registered public accounting firm may conclude that our internal controls over financial reporting are not effective or our independent registered public accounting firm may not be able to provide us with an unqualified opinion as required by Section 404 of the Sarbanes-Oxley Act. If that were to happen, investors could lose confidence in our reported financial information, which could lead to a decline in the market price of our common stock and we could be subject to sanctions or investigations by the stock exchange on which our common stock is listed, the SEC or other regulatory authorities.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
Additionally, the existence of any material weakness could require management to devote significant time and incur significant expense to remediate any such material weakness and management may not be able to remediate any such material weakness in a timely manner. The existence of any material weakness in our internal control over financial reporting also could result in errors in our financial statements that could require us to restate our financial statements, cause us to fail to meet our reporting obligations and cause the holders of our common stock to lose confidence in our reported financial information, all of which could materially adversely affect our business and share price.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
The market price of our common stock could decline as a result of sales of a large number of shares of common stock in the market, or the perception that such sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to raise capital through future sales of equity securities at a time and at a price that we deem appropriate, or at all.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RewordedRisk Factors
As the exchange rate of the U.S. dollar strengthens, as occurred in 2024 and as we expect will continue to occur in 2025 with respect to the Mexican peso, our reported international revenues and earnings are reduced because foreign currencies translate into fewer U.S. dollars.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
The ability of our operating subsidiaries to pay dividends or to make distributions or other payments to their parent companies or directly to us will depend on their respective operating results and may be restricted by, among other things, the laws of their respective jurisdictions of organization, regulatory requirements, agreements entered into by those operating subsidiaries and the covenants of any existing or future outstanding indebtedness that we or our subsidiaries may incur.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
There is no assurance that we will We may not be able to maintain or accelerate the current growth rate, effectively manage expanding operations, build operations or building new campuses, expand capacity at current locations, or achieve planned growth on a timely or profitable basis.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, a number of our institutions in Mexico and Peru are located in areas that are prone to earthquake damage.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
If any expansion initiative underperforms or does not proceed as planned, or our revenue growth is less than projected, the costs incurred for these additions and upgrades could have a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
If a country in which we operate is designated as a highly inflationary economy in the future under GAAP, the U.S. dollar would become the functional currency for our operations in that country.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
We have In the ordinary course, we do not recorded record deferred tax liabilities for undistributed foreign earnings because our strategy is to reinvest these earnings outside the United States.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any computer system error or failure, delay or unsuccessful implementation of new or enhanced systems, or a sudden and significant increase in traffic on our institutions’ computer networks or those of our third-party providers, may result in the unavailability of these computer networks.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, in 2017, a magnitude 7.1 earthquake struck Mexico, causing a temporary suspension of activities at several UVM and UNITEC campuses that lasted 12 days on average, and we incurred significant direct costs for repairs due to the earthquake.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
Other competitors may include large, well-capitalized companies that may pursue a strategy similar to ours of expanding campuses, adding on-campus or online programs or acquiring or establishing for-profit institutions.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
For the year ended December 31, 2024, 2025, a hypothetical 10% adverse change in average annual foreign currency exchange rates would have decreased our revenue, operating income and Adjusted EBITDA by approximately $156.6 $170.2 million, $43.6 $49.7 million and $50.4 $57.3 million, respectively.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedRisk Factors
Given the volatility of exchange rates, there is no assurance that we will may not be able to effectively manage currency transaction and/or translation risks.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
Share-based compensation expense increased by $5.5 million to $13.3 million for 2025 from $7.8 million for 2024, which was primarily driven by executive retention awards of restricted stock units that were granted in May 2024 and January 2025 as well as increased expense related to performance-based awards.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
•On an organic constant currency basis, revenue increased by 9% compared to 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
•On an organic constant currency basis, Adjusted EBITDA increased by 17% compared to 2024, primarily driven by revenue growth and productivity gains.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
•On an organic constant currency basis, revenue increased by 10% compared to 2023.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
•On an organic constant currency basis, revenue increased by 7% compared to 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
•On an organic constant currency basis, revenue increased by 4% compared to 2023.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
On September 13, 2024, the Company announced that its Board of Directors had approved a new stock repurchase program to acquire up to $100 million of the Company’s common stock. On October 30, 2025, the Company announced that its Board of Directors had approved a $150 million increase to the authorization for the Company’s stock repurchase program. As of December 31, 2025, the dollar value of shares yet to be repurchased under this stock repurchase program was $30.9 million. On February 19, 2026, the Company announced that its Board of Directors had approved an additional $150 million increase to the existing authorization for the Company’s stock repurchase program. After giving effect to this new authorization and taking into account the cumulative repurchases through December 31, 2025, the Company may repurchase up to $180.9 million of its common stock under its stock repurchase program, which has no fixed expiration date.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
AddedMD&A
investing cash flows due to run-out activity from previously sold discontinued operations, primarily related to a payment made in 2024 to settle an indemnification claim in connection with the 2021 sale of the Walden Group.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RemovedMD&A
(c) EiP implementation expenses were related to our enterprise-wide initiative to optimize and standardize Laureate’s processes, creating vertical integration of procurement, information technology, finance, accounting and human resources. It included the establishment of regional shared services organizations (SSOs), as well as improvements to the Company's system of internal controls over financial reporting. The EiP initiative also included other back- and mid-office areas, as well as certain student-facing activities, expenses associated with streamlining the organizational structure, an enterprise-wide program aimed at revenue growth, and certain non-recurring costs incurred in connection with previous dispositions. The EiP initiative was completed as of December 31, 2021, except for certain EiP expenses during 2022 related to the run out of programs that began in prior periods.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•Organic enrollment increased during 2024 by 8%, increasing revenues by $59.8 million.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
(2) Other is composed of acquisition-related contingent liabilities for taxes other-than-income tax, net of changes in recorded indemnification assets.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•Organic enrollment increased during 2023 by 10%, increasing revenues by $52.2 million.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•Organic enrollment increased during 2024 by 2%, increasing revenues by $13.8 million.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•Organic enrollment increased during 2023 by 6%, increasing revenues by $27.1 million.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
(in millions) 2024 2023 2022 Cash provided by (used in): Operating activities $ 232.7 $ 250.8 $ 178.2 Investing activities (57.5) (51.9) 30.3 Financing activities (166.9) (201.9) (461.6) Effects of exchange rate changes on cash (7.5) 6.6 1.2 Change in cash included in current assets held for sale 0.3 (0.5) — Net change in cash and cash equivalents and restricted cash $ 1.0 $ 3.1 $ (251.8)
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RewordedMD&A
This decrease in operating cash inflows was attributable to an increase in (2) lower cash paid for taxes of $23.5 $31.4 million, from $171.3 million in 2023 to $194.8 million in 2024, 2024 to $163.4 million in 2025, which was primarily driven by taxes paid during 2024 as a result of the distribution of certain intercompany loans. loans; and (3) lower cash paid for interest of $7.6 million, from $16.6 million in 2024 to $9.0 million in 2025, mostly due to lower average debt balances in 2025 compared to 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
The Senior Secured Credit Facility, pursuant to the Third Amended and Restated Credit Agreement, dated as of October 7, 2019 (the “Credit Agreement”, as amended by the First Amendment, dated as of July 20, 2020, the Second Amendment, dated as of December 23, 2022, and, as further amended by the Third Amendment, dated as of September 18, 2023, the “Amended Credit Agreement”), provided provides for borrowings of $145.0 million of revolving credit loans, which matured on October 7, 2024 (the “Series 2024 Tranche”) and $155.0 million of revolving credit loans maturing in September 2028 (the "Series 2028 Tranche") for a $300.0 million aggregate revolving credit facility (the “Revolving Credit Facility”).
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, (2) the effect of changes in tuition rates and enrollments in programs at varying price points (“product mix”), pricing and timing timing, which increased revenues by $34.8 $40.5 million compared to 2023. 2024; and (3) the net effect of changes in foreign currency exchange rates, which increased revenues by $2.5 million.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Other non-operating (expense) income (expense) changed by $123.0 $77.1 million to an expense of $(26.6) million for 2025 from income of $50.5 million for 2024 from expense of $(72.5) million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Cash provided by operating activities decreased increased by $18.1 $133.5 million to $366.2 million for 2025, compared to $232.7 million for 2024, compared to $250.8 million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
These increases were partially offset by changes in Other Corporate and Eliminations changes which accounted for an increase a decrease in revenues of $0.2 $0.1 million.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Our total capital expenditures, excluding receipts from the sale of subsidiaries and property and equipment, were $103.0 million, $71.9 million, million and $56.5 million during 2025, 2024 and $53.1 million during 2024, 2023 and 2022, 2023, respectively.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Cash used in financing activities decreased increased by $35.0 $55.6 million to $(222.5) million for 2025 from $(166.9) million for 2024 from $(201.9) million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
This increase in operating income was primarily a result of higher operating income at our Mexico and Peru segments, combined with lower operating costs at Corporate, segments as compared to 2022. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Revenues increased by $82.3 $135.3 million to $1,701.9 million for 2025 from $1,566.6 million for 2024 from $1,484.3 million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Direct costs and general and administrative expenses combined increased by $50.3 $78.2 million to $1,270.9 million for 2025 from $1,192.7 million for 2024 from $1,142.4 million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
RewordedMD&A
Income tax expense decreased by $18.6 $1.7 million to $117.3 million for 2025 from $119.0 million for 2024 from $137.6 million for 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new
Quiet changesMD&A
We will continue to monitor pending legislation and implementation by individual countries in which we operate, and we do not expect the global minimum tax provisions to have a material impact on our results of operations, financial position or cash flows.
Read it in 10-K Feb 19, 2026 at sec.govopen_in_new